SavedAdd your journal

Journals / Ankara Üniversitesi Veteriner Fakültesi Dergisi / 2021 / Cilt: 68 - Sayı: 1

Long-term prospective assessment of subconjunctival triamcinolone acetonide in addition to topicaltherapy in the management of chronic superficial keratitis

Florin BETEG
Cosmin MUREȘAN
Cristina Alexa LELESCU
Andrada Elena URDĂ CÎMPEA
Marian Aurel TAULESCU
Pages
61–68
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Clinically significant reductions in corneal pigmentation (P

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Chronic superficial keratitis (CSK) is a progressive inflammatory disease in adult dogs, associated with corneal vascular proliferation, edema and melanic pigment deposition.
📊
Key Findings & Data:In the absence of a curative therapy, the current approach for the management of CSK aims to control disease progression and eventually decrease the severity of corneal lesions.
💡
Conclusion & Impact:Clinically significant reductions in corneal pigmentation (P
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Chronic superficial keratitis (CSK) is a progressive inflammatory disease in adult dogs, associated with corneal vascular proliferation, edema and melanic pigment deposition. In the absence of a curative therapy, the current approach for the management of CSK aims to control disease progression and eventually decrease the severity of corneal lesions. Subconjunctival injections of corticosteroids may be effective in severe cases, where topical therapy alone is inadequate. The aim of this study was to comprehensively evaluate the effectiveness of subconjunctival triamcinolone acetonide (TA) injection in addition to topical steroid treatment for the long-term management of CSK, in dogs unresponsive to conventional topical steroids. Treatment efficacy was assessed in 11 dogs with bilateral CSK by periodic evaluation of the cornea in terms of vascularization, edema and pigmentation for up to 120 weeks. Clinically significant reductions in corneal pigmentation (P

🔖

Cite This Article

BETEG, F., MUREȘAN, C., LELESCU, C. A., CÎMPEA, A. E. U., TAULESCU, M. A. (2022). Long-term prospective assessment of subconjunctival triamcinolone acetonide in addition to topicaltherapy in the management of chronic superficial keratitis. Ankara Üniversitesi Veteriner Fakültesi Dergisi, Cilt: 68 - Sayı: 1, 61–68. https://ajindex.com/articles/444419

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Allgoever I, Hoecht S (2010): Radiotherapy for canine chronic superficial keratitis using soft X- rays. Vet Ophthalmol, 13, 20-25
  2. Athanasiadis I, de Wit D, Patel AK, et al (2012): Subconjunctival injection of triamcinolone acetonide in the management of corneal graft rejection and new vessels. J Clin Pharmacol, 52, 607-612
  3. Azoulay T (2013): Adjunctive cryotherapy for pigmentary keratitis in dogs: a study of 16 corneas. Vet Ophthalmol, 17, 241-249
  4. Balicki I (2012): Clinical study on the application of tacrolimus and DMSO in the treatment of chronic superficial keratitis in dogs. Polish J Vet Sci, 15, 667-676
  5. Bedford PGC (1972): The treatment of keratitis and corneal ulceration in the dog. Vet Ann, 13
  6. Costa DC, de Castro RS, Kara-Jose N (2009): Casecontrol study of subconjunctival triamcinolone acetonide injection vs intravenous methylprednisolone pulse in the treatment of endothelial corneal allograft rejection. Eye, 23, 708-714
  7. Croasdale CR, Brightbill MD (1999): Subconjunctival Corticosteroid Injections for Nonnecrotizing Anterior Scleritis. Arch Ophthalmol, 117, 978-979. 8. de la Maza MS, Jabbur NS, Foster CS (1993): An analysis of therapeutic decision for scleritis. Ophthalmology, 100, 1372-1376
  8. Denk N, Fritsche J, Reese S (2011): The effect of UVblocking contact lenses as a therapy for canince chronic superficial keratitis. Vet Ophthalmol, 14, 186-194
  9. Esson DW (2015): Clinical atlas of canine and feline ophthalmic disease. JohnWiley & Sons Inc, Ames, Iowa
  10. Grossmann C, Scholz T, Rochel M, et al (2004): Transactivation via the human glucocorticoid and mineralocorticoid receptor by therapeutically used steroids in CV-1 cells: a comparison of their glucocorticoid and mineralocorticoid properties. Eur J Endocrinol, 151, 397- 406
  11. Grüning G, Allgoewer I, Höcht S, et al (2001): Zur strahlentherapie der keratitis superficialis chronica mit strontium 90. Kleintierpraxis, 46
  12. Hallstrom M (1970): Synspunkter ph behandling av keratitis chronica superficialis. Svensk Veterinartidning, 22
  13. Hardman JG, Limbird LE, Gilman AG (2001): Goodman & Gilman’s The Pharmacological Basis of Therapeutics. McGraw Hill, New York
  14. Jermak CM, Dellacroce JT, Heffez J, et al (2007): Triamcinolone acetonide in ocular therapeutics. Surv Ophthalmol, 52, 503-522
  15. Jokinen P, Rusanen EM, Kennedy LJ, et al (2011): MHC class II risk haplotype associated with canine chronic superficial keratitis in German Shepherd dogs. Vet Immunol Im